Results 191 to 200 of about 1,373,329 (318)

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Safety and Tolerability of Different Total Neoadjuvant Therapies in Patients With Locally Advanced Rectal Cancer. [PDF]

Cancer Med
Udagawa S, Osumi H, Taguchi S, Noguchi T, Sakamoto T, Matsui S, Mukai T, Yamaguchi T, Fukuoka S, Yoshino K, Shimozaki K, Wakatsuki T, Ogura M, Ooki A, Chin K, Yamaguchi K, Akiyoshi T, Shinozaki E.   +17 more
europepmc   +1 more source

Cancer cell‐intrinsic type 1 interferon: production, signaling, and outcomes within sex‐biased, female malignancies

Molecular Oncology, EarlyView.
The cell‐autonomous roles of interferon type 1 vary based on duration and intensity. While acute, robust signaling results in cancer cell cytotoxic effects, sustained, low‐level signaling is associated with tumor‐promoting effects. This review summarizes current research of IFN‐1 in cancer and within the clinical setting, with an emphasis on female ...
Ashlyn Conant, Nora Badiner, Sharon Asariah, Kiera McGivney, Vishwa Shah, Tise Suzuki, Yevgeniya J. Ioffe, Juli J. Unternaehrer   +7 more
wiley   +1 more source

Factors influencing anxiety levels in colon cancer patients undergoing chemotherapy after arm venous port implantation: An exploratory study of risk factors. [PDF]

Medicine (Baltimore)
Zhang J, Wang X, Han J.
europepmc   +1 more source

THE CHEMOTHERAPY OF HELMINTHIASIS

Journal of Pharmacy and Pharmacology, 1958
openaire   +2 more sources

Chemotherapy of Cancer [PDF]

Postgraduate Medical Journal, 1958
openaire   +2 more sources

Proteasomal degradation of intracellularly expressed Amblyomin‐X limits suicide gene therapy potential in melanoma cells

FEBS Open Bio, EarlyView.
This study explores the feasibility of expressing the antitumoral protein Amblyomin‐X through a suicide gene therapy approach and investigates its intracellular fate after gene delivery. Although the gene is efficiently expressed, melanoma cells rapidly degrade the Amblyomin‐X protein via proteasome activity.
Victor Dal Posolo Cinel, Carlos DeOcesano Pereira, Aline Ramos Maia Lobba, Melissa Regina Fessel, Ana Marisa Chudzinski‐Tavassi   +4 more
wiley   +1 more source

Knowledge, attitudes, and practices toward chemotherapy resistance among oncologists: a multinational cross-sectional study. [PDF]

Front Oncol
Hassan BAR, Mohammed AH, Mohamed K, Startsev VY, Drira C, Hamdy O, Elmetwaly MMF, Nabil S, Alshehhi S, Othman G, Al-Hussaini HHY, Alsammarraie AZA, Abid A, Kassem NM, Khatib SE, Hallit S, Malaeb D, Hosseini H.   +17 more
europepmc   +1 more source

Intraperitoneal chemotherapy

Journal of British Surgery, 1944
openaire   +1 more source

Blood‐based proteomic profiling reveals context‐dependent changes in BCL2‐associated signaling during taxane therapy in breast cancer patients

FEBS Open Bio, EarlyView.
Chemotherapy side effects significantly impact cancer survivors' quality of life. Using protein levels in blood samples from breast cancer patients before and after 12 weeks of taxane treatment, we detected treatment‐dependent changes in calcium signaling and aging pathways associated with cancer recurrence.
Saira Munshani, Eiman Y. Ibrahim, Rozalyn L. Rodwin, Leah M. Ferrucci, Kim Blenman, Maryam Lustberg, Barbara E. Ehrlich   +6 more
wiley   +1 more source